Article Versions Notes

Opydo M, Mlyczyńska A, Mlyczyńska E, Rak A, Kolaczkowska E. Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation. International Journal of Molecular Sciences. 2023; 24(8):7180. https://doi.org/10.3390/ijms24087180

Opydo, Małgorzata, Anna Mlyczyńska, Ewa Mlyczyńska, Agnieszka Rak, and Elzbieta Kolaczkowska. 2023. "Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation" International Journal of Molecular Sciences 24, no. 8: 7180. https://doi.org/10.3390/ijms24087180

Opydo, M., Mlyczyńska, A., Mlyczyńska, E., Rak, A., & Kolaczkowska, E. (2023). Synergistic Action of MCL-1 Inhibitor with BCL-2/BCL-XL or MAPK Pathway Inhibitors Enhances Acute Myeloid Leukemia Cell Apoptosis and Differentiation. International Journal of Molecular Sciences, 24(8), 7180. https://doi.org/10.3390/ijms24087180